George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Independent Investigation Update

28 Apr 2023 07:00

RNS Number : 7852X
WANdisco Plc
28 April 2023
 

28 April 2023

WANdisco plc 

("WANdisco" or the "Company") 

Independent Investigation Update

 

WANdisco (LSE: WAND), the data activation platform, announces that the independent investigation undertaken by FRP Advisory has, based on its detailed review of the identified evidence, drawn its conclusions regarding the scope, scale and limits of the irregularities associated with received purchase orders and related revenue and sales bookings as represented by one senior sales employee. Those conclusions are that:

 

· all of the purchase orders associated with the senior sales employee in question are illegitimate;

· all other purchase orders (i.e. those not associated with or secured by the senior sales employee in question) are legitimate;

· the impact of these findings on the Company's accounts, therefore, remains as set out in the Company's announcement of 3 April 2023; and

· there is no credible evidence that there are any customers using the Company's technology and who believe they are making payments to either the Company, an authorised reseller or partner but who are instead making payments unwittingly and/or unknowingly to an unauthorised third party. However, notwithstanding that it would be technically extremely difficult for a third party to implement and deploy the Company's product without the knowledge and support of the Company, it is not possible to provide a completely definitive conclusion that there has been no unauthorised use by a third party.

 

 

These conclusions and the basis for them will now be passed to the Company's auditors, so that the process to conclude the Company's FY 2022 financial results can continue.

 

It remains the case that the evidence identified supports the initial view that the irregularities are as a result of the actions of one senior sales employee only.

 

Ongoing Workstreams

 

An update on key initiatives following FRP's continuing work to examine relevant processes and controls and other steps being taken to improve the Group's internal processes will be provided in the Annual Report and Accounts for the year ended 31 December 2022, once published.

 

The Company and Board continue to proactively engage with relevant customers, partners, and related entities with the aim of concluding this matter in a complete, thorough, and timely manner. The Board remains committed to seeking the lifting of the suspension of trading in the Company's shares on AIM as quickly as possible and is working with its Nominated Adviser to achieve this. Further updates will be made in due course as appropriate.

 

The Company is pleased to confirm that Ijoma Maluza commenced his work as Interim Chief Financial Officer on April 11, as planned, following announcement of his appointment on April 3. In addition, the Board continues to advance its process to secure a new Chief Executive Officer and to ensure that the Board has the appropriate skills, experience and balance to drive the Company's future development.

Kenneth Lever, Executive Chairman of Wandisco plc, commented:

"We are pleased to receive these findings, which confirm the limits of the impact of the identified irregularities in line with our announcement of April 3. The Board remains squarely focused on workstreams to lift the suspension of our shares as soon as is practicable and position WANdisco for long-term growth and success."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

Enquiries: 

WANdisco plc

via FTI Consulting

 

FTI Consulting

 

+44 (0)20 3727 1137

Matt Dixon / Rob Mindell / Kwaku Aning / Tom Blundell

 

 

Stifel (Nomad and Joint Broker)

 

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

 

 

Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones

 

 

About WANdisco

WANdisco is the data activation platform for accelerating digital transformation at scale. WANdisco makes infinite data actionable across clouds and enterprises in real time. WANdisco customers unleash the business value of the cloud with zero downtime, data loss, or disruption to fuel AI and machine learning, create new services, and transform businesses. For more information about WANdisco, visit: www.wandisco.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFLISFIDFIV
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.